Signal Transduction Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Signal Transduction stocks.

Signal Transduction Stocks Recent News

Date Stock Title
May 26 VSTM Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)
May 26 VSTM Verastem: Narrowed Market And Less Compelling Efficacy Warrant Rating Downgrade
May 24 VSTM Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
May 24 PBYI Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
May 24 VSTM What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
May 24 VSTM Sector Update: Health Care Stocks Advance Pre-Bell Friday
May 24 VSTM ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
May 24 VSTM Verastem whipsaws after updates for cancer drug combo
May 24 VSTM Verastem Reports Results of Potential Pancreatic Cancer Treatment, Submits Rolling New Drug Application for Rare Ovarian Cancer
May 24 VSTM Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
May 23 VSTM Verastem stock rallies on positive data for pancreatic cancer drug combo
May 23 PBYI Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
May 23 VSTM Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer​
May 22 GPCR This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21 GPCR J.P. Morgan starts Structure at overweight, cites GLP-1 drug candidate
Signal Transduction

Signal transduction is the process by which a chemical or physical signal is transmitted through a cell as a series of molecular events, most commonly protein phosphorylation catalyzed by protein kinases, which ultimately results in a cellular response. Proteins responsible for detecting stimuli are generally termed receptors, although in some cases the term sensor is used. The changes elicited by ligand binding (or signal sensing) in a receptor give rise to a signaling cascade, which is a chain of biochemical events along a signaling pathway. When signaling pathways interact with one another they form networks, which allow cellular responses to be coordinated, often by combinatorial signaling events. At the molecular level, such responses include changes in the transcription or translation of genes, and post-translational and conformational changes in proteins, as well as changes in their location. These molecular events are the basic mechanisms controlling cell growth, proliferation, metabolism and many other processes. In multicellular organisms, signal transduction pathways have evolved to regulate cell communication in a wide variety of ways.
Each component (or node) of a signaling pathway is classified according to the role it plays with respect to the initial stimulus. Ligands are termed first messengers, while receptors are the signal transducers, which then activate primary effectors. Such effectors are often linked to second messengers, which can activate secondary effectors, and so on. Depending on the efficiency of the nodes, a signal can be amplified (a concept known as signal gain), so that one signaling molecule can generate a response involving hundreds to millions of molecules. As with other signals, the transduction of biological signals is characterised by delay, noise, signal feedback and feedforward and interference, which can range from negligible to pathological. With the advent of computational biology, the analysis of signaling pathways and networks has become an essential tool to understand cellular functions and disease, including signaling rewiring mechanisms underlying responses to acquired drug resistance.

Browse All Tags